REPORT DESCRIPTION
GLOBAL MARKET WATCH
Global stem cells market is forecasts to reach US$63.8 billion by 2015 from an estimated value of US$21.5 billion in 2010, exhibiting a triple fold growth rate during the period 2010-2015. The major application use in stem cells market is classified into oncology, cardiology, and bone & cartilage. Among the applications areas, neurology is forecasts to exert highest support to the stem cells market growth with a CAGR of 24.4% during 2010-2015. Hematology and diabetes are expected to lead the stem cell market during 2010-2015. Our study on the stem cell technologies reveals that cord blood banking and xenotransplantation are expected to lead the technologies during 2010-2015. Drug discovery and stem cell transplantation techniques are also expected to ground in the upcoming years.
The stem cell market is expected to witness a substantial growth in the upcoming years, with a CAGR of 24.2%, globally. Although North America will likely post highest market value by 2015, Asian economies are expected to maintain large CAGR of 27 percent during 2010-2015. The higher growth rate indicates improved industry investments in the Asia-Pacific region in comparison with North America and Europe, going ahead.
Improving health consciousness in Europe will likely maintain the Union competent with Asia-Pacific/North America. India possesses the potential to occupy the leading position in stem cell market growth with a CAGR exceeding 28 percent through 2015. Spain, Sweden and Germany are anticipated to top among the European countries with an annual compounded growth rate of more than 27 percent respectively through 2010-2015. Latin American countries will not likely experience a massive growth rate in comparison with North American/Asian economies. Overall, emerging economies could tag higher growth rate stem cells market in the next few years.
New trends in stem cell technologies realized multidisciplinary research consortia among academic, medical, government and industry partners. Anticipating a boom in technological space, the consortia members are expected to be benefitted in the application front and in practicing stem-cell technology in life science arena.
Report Focus:
The ‘Cord Blood, Embryonic and Adult Stem Cells Applications & Technologies – A Global Market Watch, 2009-2015’ reviews the latest Stem Cells market trends with a perceptive to disclose the near-future growth prospects. An in-depth analysis across the geographic regions provides strategic business intelligence for life science and as well as healthcare sector investments. The study offers profitable investment strategies for stem cell banks, stem cells R&D organizations, pharmaceutical manufacturers, biotechnology companies, laboratories, Contract Research Organizations (CROs) and many more in preferred locations. The report primarily focuses on:
-Latest Market Trends
-Key Competitors Edge
-Investment Strategies
-Stem cell market trends in emerging markets
-Advancements in the technological space
-Demand of the market segments (by-region)
-Key growth areas and market size
The report delivers a microscopic overview of major product segments, applications and technological areas of stem cells market, regionally. The stem cells product segments include adult stem cells, cord blood stem cells, embryonic stem cells and others.
The major stem cells applications areas discussed in the report are:
-Bone & Cartilage
-Cardiac
-Skin
-Diabetes
-Blood Disorders
-Neuro
-Cancer
-Digestive System
-Drug Development
-Eyes
-Injuries
-Reproductive System and
-Others
The major stem cells technologies discussed in the report are:
-Cell Based Technologies
-Cord Blood Banking
-Cryopreservation
-Stem Cell Banking
-Stem Cell Characterization
-Stem Cell Drug Discovery
-Stem Cell Production
-Stem Cell Transplants
-Xenotransplantation and
-Others (Blood Transfusion and Molecular Biology and Others)
The report focuses on the major current market trends, estimates and forecasts for the period 2009-2015. More than 500 leading market players are identified and 37 key companies that project improved market activities in the near future are profiled. The report consists of 508 data charts describing the market shares, sales forecasts and growth prospects. Moreover, key strategic activities in the market including mergers/acquisitions, collaborations/partnerships, product launches/developments are discussed which gives a deep insight into the growth perspectives of the market.
The region-wise distribution of the market consists of North America (USA, Canada and Mexico); Europe (Belgium, Denmark, France, Germany, Greece, Spain, Sweden, United Kingdom and Rest of Europe); Asia-Pacific (Australia, China, India, Japan, South Korea and Rest of Asia-Pacific); Latin America (Argentina and Brazil) and Rest of the World (Columbia, Middle East, South Africa and Rest of Rest of World). Incorporating the recession impacts on the industry, the market growth rate in the major economies such as the U.S., Japan and China along with the other emerging countries are estimated individually for the upcoming years. Anticipating a protracted economic recovery towards to 2011 and based on the CAGR estimates and growth potential, we have forecasted the market size figures for the next five years.
Estimates are based on online surveys using customized questionnaires by our research team. Besides information from government databases, company websites, press releases and published research reports are also used for estimates. Estimates have incorporated recessionary impact on the Stem Cells industry.
Some companies mentioned out of 500 companies:
AASTROM BIOSCIENCES, INC.
ACORDA THERAPEUTICS, INC.
ADVANCED CELL TECHNOLOGY, INC.
AFFYMETRIX, INC
ALPHA CORD, INC
ANGIOBLAST SYSTEMS, INC.
BIOHEART, INC
BOEHRINGER-INGELHEIM GMBH
CELL THERAPEUTICS, INC.
CELLS4LIFE LTD.
CORCELL, INC.
CORD BLOOD REGISTRY
CORDLIFE LTD.
CRYOCORD SDN. BHD.
And many more…………
Global Biological Therapy Industry
TABLE OF CONTENTS
I. REPORT FOCUS
A. INTRODUCTION
FUNCTIONS OF STEM CELLS
STEM CELL APPLICATIONS
STEM CELL MILESTONES
DEFINITION AND IMPORTANCE
STEM CELL DEBATE
CONCLUSION
B. STEM CELLS – THE BEGINNING OF ALL BLOOD CELLS
ADULT STEM CELLS
EMBRYONIC STEM CELLS
UMBILICAL CORD BLOOD STEM CELLS
TOTIPOTENT STEM CELLS
PLURIPOTENT STEM CELLS
MULTIPOTENT STEM CELLS
OLIGOPOTENT STEM CELLS
UNIPOTENT STEM CELLS
INDUCED PLURIPOTENT STEM CELLS (IPSCS)
DISEASE DETECTION
CHALLENGES TO CULTURE
STANDARD GUIDELINE FOR IPS TECHNOLOGY
C. ADVANCES IN STEM CELL RESEARCH
D. SIMILARITIES AND DIFFERENCES BETWEEN EMBRYONIC AND ADULT STEM CELLS
E. THE CONTROVERSY ON STEM CELL
STEM CELLS BACKGROUND
OUTLOOK
ARGUMENT
PROPER USE
TRANSCENDENCE
THE BEGINNING
LIFE IMPORTANCE
F. A REVIEW ON ADULT STEM CELLS
THE ROLE OF ADULT STEM CELLS IN TISSUE REPAIR
ADULT STEM CELLS AND CANCER
FIRST TRANSPLANTATION OF HUMAN ORGAN GROWN FROM ADULT STEM CELLS
ADVANTAGES OF ADULT BM CELLS TRANSPLANTATION IN CARDIOLOGY
CONCLUSION
G. A REVIEW ON EMBRYONIC STEM CELLS
HISTORY
MAJOR SUPPORT TO EMBRYONIC STEM CELL RESEARCH
A COMBINED EFFORT
CONFUSING LEGISLATION
REWARDING THE DESERVING
GOVERNMENTAL POLICY IN DIFFERENT REGIONS
AMERICANS
UNITED STATES
EUROPE
ASIA-PACIFIC
AFRICA
EMBRYONIC STEM CELL RESEARCH “CONTROVERSY”
CREATION OF EMBRYONIC CHARACTERISTICS FROM HUMAN UMBILICAL CORD BLOOD
HUMAN EMBRYONIC STEM CELLS (HES) CLASSIFICATION AND DIFFERENTIATION
ORIGIN, EXPANSION AND APPLICATIONS OF HUMAN EMBRYONIC STEM CELLS
ADVANTAGES OF ES CELL TRANSPLANTATION IN CARDIOLOGY
H. A REVIEW ON CORD BLOOD STEM CELLS
ENHANCEMENTS
USES OF CORD BLOOD BANKING
FOCUS AND SCOPE OF COMPANIES INTO CORD BLOOD STEM CELLS
BMSN (BIO-MATRIX SCIENTIFIC GROUP, INC.)
MEDISTEM INC.
CRYO-CELL INTERNATIONAL, INC.
GLANCE AT U.S PRIVATE FAMILY BANKS
CORD BLOOD AMERICA, INC.
VIACELL, INC.
OTHER COMPANIES
PROGRESS IN CORD BLOOD COLLECTION, PROCESSING AND TRANSPLANTATION
TIGHT MEASURES AND CERTIFICATIONS
TEST ON STEM CELLS FROM BLOOD CORD
I. ROLE OF STEM CELLS IN VARIOUS APPLICATIONS
ROLE OF STEM CELLS IN BONE & CARTILAGE
CURRENT DEVELOPMENTS
REPAIR OF CARTILAGE AND BONE WITH STEM CELLS
ROLE OF ADULT STEM CELLS IN BONE AND CARTILAGE TISSUE ENGINEERING
CARTILAGE AND BONE REBUILDING
ROLE OF STEM CELLS IN CARDIAC
BACKGROUND
INTRODUCTION
ADULT CARDIAC STEM (ACS) CELLS
MARKERS OF STEM CELL-DERIVED CARDIOMYOCYTE DIFFERENTIATION
MYOCARDIAL TRANSPLANTS: ADVANTAGES AND LIMITATIONS ASSOCIATED
WITH DIFFERENT CELL-TYPES
ROLE OF STEM CELLS IN SKIN
UNDERSTANDING CELL TYPES
SOMATIC STEM CELLS IN DERMATOLOGY
STEM CELLS AND THEIR OFFSPRING ARRANGEMENT IN HUMAN EPIDERMIS
SCLERODERMA PATIENTS GAIN FROM STEM CELL THERAPY
ROLE OF STEM CELLS IN DIABETES
STEM CELLS 'CURE DIABETES'
DIABETES STEM-CELL TREATMENT LOOKS TO CELL CAPSULES
GROWTH OF CELL-BASED THERAPIES FOR DIABETES
FUTURE OF DIABETES WITH STEM CELLS THERAPY
ROLE OF STEM CELLS IN BLOOD DISORDERS
HEMATOPOIETIC BEGINNING OF HEPATIC STELLATE CELLS IN THE MATURE LIVER
TIME FROM ANALYSIS TO CURING COMMENCEMENT FORETELL SURVIVAL IN YOUNGER AND NOT OLDER,
SEVERE MYELOID LEUKEMIA PATIENTS
ENDURING PRESERVATION OF HUMAN HEMATOPOIETIC STEM/PROGENITOR CELLS BY
APPEARANCE OF BMI1
SIGNALING PATHWAYS GOVERNING STEM-CELL FATE
HEMATOLOGICAL EFFECT OF STEM CELL FACTOR (IN-VIVO AND IN-VITRO) ON RATS
IS FAT TISSUE A RESOURCE OF PRICELESS BLOOD STEM CELLS?
ROLE OF STEM CELLS IN NEURO
STEM CELLS PROGRESS FOR THE CURE OF NEUROLOGICAL DISORDERS
USAGE OF STEM CELLS IN NEUROLOGICAL DISEASES (HOPE OR HYPE)
STEM CELLS APPLIED IN NERVOUS SYSTEM REPAIR
STEM CELLS ACT THROUGH VARIOUS METHODS TO BENEFIT MICE WITH NEURODEGENERATIVE ILLNESS
ROLE OF STEM CELLS IN CANCER
OPTION OF RESOURCE OF STEM CELLS FOR CANCER THERAPY
CANCER STEM CELLS AND ONCOLOGY THERAPEUTICS
CANCER STEM CELL SUGGESTION IN THYROID CANCER
FUTURE POTENTIALS
J. STEM CELLS TECHNOLOGY
AUTOMATED STEM CELL CULTURE WITH GREATER CONSISTENCY
RESTRICTIONS OBSERVED IN THE MANUAL CULTIVATION
AUTOMATION SOLUTION
CONSISTENCY AND REPRODUCIBILITY
K. STEM CELLS IN VARIOUS TECHNOLOGIES
CELL BASED TECHNOLOGIES
A) HEART DISEASE OR AILMENT
B) DIABETES
C) STEM CELL THERAPY OR TREATMENT FOR DIABETES
D) PARKINSON'S DISEASE
CORD BLOOD BANKING
PUBLIC BANKS
PRIVATE BANKS
CRYOPRESERVATION
STEM CELL BANKING
STEM CELL CHARACTERIZATION
STEM CELL DRUG DISCOVERY
EMBRYONIC STEM CELLS AS A SOURCE OF MODELS FOR DRUG DISCOVERY
STEM CELL PRODUCTION
NEW WAY OF PRODUCING STEM CELLS FOUND
STEM CELL TRANSPLANTS
XENOTRANSPLANTAION
BLOOD TRANSFUSION
MOLECULAR BIOLOGY
II. MARKET ANALYSIS
STEM CELLS MARKET AND APPLICATIONS – SNAPSHOT
A. STEM CELLS MARKET AND APPLICATIONS – SEGMENTATION
B. STEM CELLS – BY COUNTRY
NORTH AMERICA
EUROPE
ASIA-PACIFIC
LATIN AMERICA
REST OF WORLD
C. STEM CELLS – PRODUCT SEGMENTS
C1. STEM CELL PRODUCT SEGMENTS - GEOGRAPHIC REGION
ADULT STEM CELLS
NORTH AMERICA
EUROPE
ASIA-PACIFIC
LATIN AMERICA
REST OF WORLD
CORD BLOOD STEM CELLS
NORTH AMERICA
EUROPE
ASIA-PACIFIC
LATIN AMERICA
REST OF WORLD
EMBRYONIC STEM CELLS
NORTH AMERICA
EUROPE
ASIA-PACIFIC
LATIN AMERICA
REST OF WORLD
OTHER STEM CELLS
NORTH AMERICA
EUROPE
ASIA-PACIFIC
LATIN AMERICA
REST OF WORLD
C2. STEM CELLS – BY PRODUCT
NORTH AMERICA
THE USA
CANADA
MEXICO
EUROPE
BELGIUM
DENMARK
FRANCE
GERMANY
GREECE
SPAIN
SWEDEN
THE UNITED KINGDOM
REST OF EUROPE
ASIA-PACIFIC
AUSTRALIA
CHINA
INDIA
JAPAN
SOUTH KOREA
REST OF ASIA-PACIFIC
LATIN AMERICA
ARGENTINA
BRAZIL
REST OF WORLD
COLUMBIA
MIDDLE EAST
SOUTH AFRICA
REST OF REST OF THE WORLD
D. STEM CELLS - APPLICATIONS
STEM CELL - APPLICATIONS - GEOGRAPHIC REGION
BONE & CARTILAGE
NORTH AMERICA
EUROPE
ASIA-PACIFIC
LATIN AMERICA
REST OF WORLD
CARDIAC
NORTH AMERICA
EUROPE
ASIA-PACIFIC
LATIN AMERICA
REST OF WORLD
SKIN
NORTH AMERICA
EUROPE
ASIA-PACIFIC
LATIN AMERICA
REST OF WORLD
DIABETES
NORTH AMERICA
EUROPE
ASIA-PACIFIC
LATIN AMERICA
REST OF WORLD
BLOOD DISORDERS
NORTH AMERICA
EUROPE
ASIA-PACIFIC
LATIN AMERICA
REST OF WORLD
NEURO
NORTH AMERICA
EUROPE
ASIA-PACIFIC
LATIN AMERICA
REST OF WORLD
CANCER
NORTH AMERICA
EUROPE
ASIA-PACIFIC
LATIN AMERICA
REST OF WORLD
OTHERS*
NORTH AMERICA
EUROPE
ASIA-PACIFIC
LATIN AMERICA
REST OF WORLD
DIGESTIVE SYSTEM
DRUG DEVELOPMENT
EYES
INJURIES
REPRODUCTIVE SYSTEM
OTHERS
E. STEM CELLS - TECHNOLOGIES
STEM CELLS - TECHNOLOGIES - GEOGRAPHIC REGION
CELL BASED TECHNOLOGIES
NORTH AMERICA
EUROPE
ASIA-PACIFIC
LATIN AMERICA
REST OF WORLD
CORD BLOOD BANKING
NORTH AMERICA
EUROPE
ASIA-PACIFIC
LATIN AMERICA
REST OF WORLD
CRYOPRESERVATION
NORTH AMERICA
EUROPE
ASIA-PACIFIC
LATIN AMERICA
REST OF WORLD
STEM CELL BANKING
NORTH AMERICA
EUROPE
ASIA-PACIFIC
LATIN AMERICA
REST OF WORLD
STEM CELL CHARACTERIZATION
NORTH AMERICA
EUROPE
ASIA-PACIFIC
LATIN AMERICA
REST OF WORLD
STEM CELL DRUG DISCOVERY
NORTH AMERICA
EUROPE
ASIA-PACIFIC
LATIN AMERICA
REST OF WORLD
STEM CELL PRODUCTION
NORTH AMERICA
EUROPE
ASIA-PACIFIC
LATIN AMERICA
REST OF WORLD
STEM CELL TRANSPLANTS
NORTH AMERICA
EUROPE
ASIA-PACIFIC
LATIN AMERICA
REST OF WORLD
XENOTRANSPLANTATION
NORTH AMERICA
EUROPE
ASIA-PACIFIC
LATIN AMERICA
REST OF WORLD
OTHERS
NORTH AMERICA
EUROPE
ASIA-PACIFIC
LATIN AMERICA
REST OF WORLD
F. STEM CELLS – BY APPLICATION
NORTH AMERICA
THE USA
CANADA
MEXICO
EUROPE
BELGIUM
DENMARK
FRANCE
GERMANY
GREECE
SPAIN
SWEDEN
THE UNITED KINGDOM
REST OF EUROPE
ASIA-PACIFIC
AUSTRALIA
CHINA
INDIA
JAPAN
SOUTH KOREA
REST OF THE ASIA-PACIFIC
LATIN AMERICA
ARGENTINA
BRAZIL
REST OF WORLD
COLUMBIA
MIDDLE EAST
SOUTH AFRICA
REST OF REST OF WORLD
G. STEM CELLS – BY TECHNOLOGIES
NORTH AMERICA
THE USA
CANADA
MEXICO
EUROPE
BELGIUM
DENMARK
FRANCE
GERMANY
GREECE
SPAIN
SWEDEN
THE UNITED KINGDOM
REST OF EUROPE
ASIA-PACIFIC
AUSTRALIA
CHINA
INDIA
JAPAN
SOUTH KOREA
REST OF ASIA-PACIFIC
LATIN AMERICA
ARGENTINA
BRAZIL
REST OF WORLD
COLUMBIA
MIDDLE EAST
SOUTH AFRICA
REST OF REST OF WORLD
H. GROWTH RATE ANALYSIS
GLOBAL STEM CELLS PRODUCTS, APPLICATIONS AND TECHNOLOGIES GROWTH RATES
STEM CELLS - PRODUCT SEGMENTS
GLOBAL STEM CELLS PRODUCT SEGMENTS MARKET GROWTH RATES
ADULT STEM CELLS
CORD BLOOD STEM CELLS
EMBRYONIC STEM CELLS
STEM CELLS - APPLICATIONS
GLOBAL STEM CELL APPLICATIONS MARKET GROWTH RATES
BONE & CARTILAGE
CARDIAC
SKIN
DIABETES
BLOOD DISORDERS
NEURO
CANCER
DIGESTIVE SYSTEM
DRUG DEVELOPMENT
EYES
INJURIES
REPRODUCTIVE SYSTEM
STEM CELL - TECHNOLOGIES
GLOBAL STEM CELL TECHNOLOGIES MARKET GROWTH RATES
CORD BLOOD BANKING
STEM CELL CHARACTERIZATION
XENOTRANSPLANTATION
STEM CELL DRUG DISCOVERY
STEM CELL TRANSPLANTS
STEM CELL PRODUCTION
STEM CELL BANKING
CRYOPRESERVATION
CELL BASED TECHNOLOGIES
F. INVESTMENT FOCUS
III. INDUSTRY OVERVIEW
A. INDUSTRY ACTIVITIES
MERGERS/ACQUISITIONS/AGREEMENTS/PATENTS GRANTS/JOINT VENTURES/etc……
SPECIAL HUMAN CELLS DERIVED FROM STEM CELLS RESTORE MOVEMENT IN RATS WITH SPINAL CORD INJURY
ASTROCYTES DERIVED FROM HUMAN STEM CELLS IMPROVE THE LOCOMOTOR FUNCTIONS OF RATS WITH SPINAL CORD INJURY
CORD BLOOD AMERICA PURCHASE OF CORD BLOOD STEM CELLS STORED BY REPRODUCTIVE GENERATIVE INSTITUTE AN ILLINOIS FIRM
LIFESPAN OF BONE MARROW STEM CELLS PREDICTED THROUGH COMPUTER MODEL, SOLVES THE REGENERATIVE PROBLEMS
RECENT STUDY REVEAL A COMBINATION OF CELLASTIM AND OPTIFERRIN IS IDEAL FOR STEM CELL EXPANSION WHICH REPLACES NEED OF BLOOD PRODUCTS
SINGLE BLASTOMERE TECHNOLOGY SECURES PATENT TO GENERATE EMBRYONIC STEM CELLS ENSURING EMBRYO SAFETY
MESENCHYMAL STEM CELLS TO IMPROVE THE DAMAGED CELLS AFTER HEART ATTACK
STEMCELLS, INC. COMPLETES SECOND TRIAL OF HUCNS-SC(R) NEURAL STEM CELLS, A POTENTIAL TREATMENT FOR MYELINATION DISORDER
AMNIOTIC FLUID COLLECTED DURING THIRD TRIMESTER IS A RELIABLE SOURCE OF STEM CELLS FOR REGENERATIVE MEDICINE AND STEM CELL BANKING
CORD BLOOD AMERICA, INC. ANNOUNCES PURCHASE OF MINORITY INTEREST IN VIDAPLUS EXPECTED TO GAIN REVENUE AND POPULARITY IN EUROPE
INDUCED PLURIPOTENT STEM CELLS ARE SAFER AND CANCEROUS GROWTH MAY BE AVOIDED
MICRORNAS ENHANCES THE GENERATION OF INDUCED PLURIPOTENT STEM CELLS (IPS), THROUGH REPROGRAMMING SKIN STEM CELLS
ROLE OF STEM CELLS IN REPAIRING DAMAGED HEART OF CHILDREN
THE FRAUNHOFER INSTITUTE IS FOCUSED TO STUDY THE CELL THERAPEUTIC PROCESSES IN ORDER TO OFFER SUITABLE SOLUTIONS
MIRNA THERAPEUTICS, INC. PUBLISH NEW DATA ON MIR-34 IN INHIBITING THE GROWTH OF CANCER CELLS
BIOCELLS, INC., TO STORE DENTAL PULP STEM CELLS WHICH AIDS IN STIMULATING NEURAL CELLS AND A SOURCE OF REGENERATIVE MEDICINE
NEOSTEM, INC.'S RECOMMENDED FOR THE FINANCIAL AWARD OF $1,700,000 TO DEVELOP VERY SMALL EMBRYONIC-LIKE STEM CELLS WHICH IS A POTENTIAL CURE FOR OSTEOPOROSIS FROM DEPARTMENT OF DEFENSE PEER REVIEWED MEDICAL RESEARCH PROGRAM
BIOHEART REPORTS THE USE OF ADIPOSE DERIVED STEM CELLS IN CURING CRITICAL LIMB ISCHEMIA
POSITION OF DNA IN STEM CELL TRANSPLANT SUCCESS & FUNDING
THE CHEAPEST STEM CELL TRANSPLANT FROM INDIA
HUMAN STEM CELLS CALLED PARTHENOGENETIC CELLS, WHICH ARE DEVELOPED BY UNFERTILIZED HUMAN EGGS-ETHICAL CONSIDERATIONS AND MEDICAL ADVANTAGES
ADVANCED CELL TECHNOLOGY AND THE ROSLIN INSTITUTE ANNOUNCE AGREEMENT FOR STORAGE AND DISTRIBUTION OF EMBRYONIC STEM CELLS USING ACT'S BLASTOMERE TECHNOLOGY
STEM CELL TECHNOLOGY - A BREAKTHROUGH IN GROWING FUNCTIONAL INTESTINE TISSUE
ADVANCED CELL TECHNOLOGY CLEARED BY FDA FOR THE FIRST CLINICAL TRIAL ON USING RETINAL STEM CELLS FOR CURING STARGARDT’S MACULAR DYSTROPHY
EHSI: STEM CELLS COULD HELP HEART ATTACK VICTIMS
STEMCYTE, INC. RECEIVED TWO AWARDS TOTALING TO $488,950 FOR ADVANCED THERAPEUTIC APPLICATIONS OF UMBILICAL CORD BLOOD STEM CELLS FROM THE QUALIFYING THERAPEUTIC DISCOVERY PROJECT (QTDP)
SHRINK NANOTECHNOLOGIES REVEALS VIDEOS OF STEMDISC450 PROTOTYPE, A DEVICE FOR GROWING HUMAN EMBRYONIC STEM CELLS
X-BODY BIOSCIENCES AWARDED GRANT FOR THERAPEUTIC DISCOVERY PROJECT TARGETING METASTATIC TUMOR STEM CELLS
STEM CELLS REPAIR DAMAGED SPINAL CORD TISSUE IN RATS
ROCHE´S CELLAVISTA SYSTEM ENHANCES THE STUDY OF SELF RENEWAL OF EMBRYONIC STEM CELLS
GERON ENTERS INTO A LICENSE AGREEMENT FOR PRODUCTION OF CHONDOCYTES FROM IPS
GUIDED ADULT STEM CELLS CAN EFFECTIVELY REPAIR HEARTS
NEW CULTURE DISH OVERCOMES THE LIMITATIONS IN HUMAN EMBRYONIC STEM CELL RESEARCH
STEM CELL THERAPY A MAJOR ROLE FOR ACUTE LUNG DAMAGE IN MICE
NEW APPROACH IN MEDICAL APPLICATION OF RESOURCEFUL AND PROTECTED PLURIPOTENT STEM CELLS FOR ENGENDERING
REGENERATIVE STEM CELL TREATMENTS WITH PATIENTS HAVING CONGESTIVE HEART FAILURE BIOHEART THERAPIES
STEM CELL MODULATOR PIPELINE WITH ACQUISITION OF FATE THERAPEUTICS WITH VERIO THERAPEUTICS
SRU BIOSYSTEMS ANNOUNCES INTRODUCTION OF BIND(R) SCANNER FOR PRIMARY AND STEM CELL APPLICATIONS
NEW PROGRESS DIRECTED TO A GET THROUGH PROCESS FOR EXTENDED MEDICAL APPLICATION OF MATURE STEM CELLS
AGREEMENT FOR PATENT AND CULTIVATION OF PLURIPOTENT STEM CELLS
APPLICATION ON CHEMOKINE TECHNOLOGY TO INCREASE EFFICACY OF TISSUE-SPECIFIC STEM CELL HOMING IN COPD TREATMENT
TESTING OF RETINAL PIGMENT FROM HUMAN PARTHENOGENETIC STEM CELLS
AUGMENTATION FEATURE HELP STEM CELL GROWTH: REGENERATION
ADULT ALLOGENEIC MESENCHYMAL STEM CELLS TREATMENT FOR STROKE FROM STEMEDICA CELL TECHNOLOGIES, INC
STEM CELL MANUFACTURING FOR STROKE AND CLINICAL TRIAL FROM RENEURON GROUP PLC
PATENT GRAND FOR PLURIPOTENT RAT STEM CELLS AND GENETICALLY ENGINEERED RATS FOR STEMCELLS, INC.
STEM CELLS BUILD NEW BLOOD VESSELS FOR THE TREATMENT PERIPHERAL ARTERIAL DISEASE
PROPRIETARY ADULT STEM CELL LINES FORMATION
THE SYNTHEMAX(TM) SURFACE FOR SCALABLE GROWTH OF HUMAN EMBRYO DEVELOPED BY GERON CORPORATION AND CORNING INCORPORATED.
STEM CELL INNOVATIONS TO OFFER AGENNIX THE RESEARCH AND ASSAY SERVICES
CARDIAC STEM CELL THERAPY PRESENTATION - BMT TANDEM MEET BY OSIRIS THERAPEUTICS
STEM CELL THERAPY FOR CARDIAC DISEASES
EFFECTIVE USE OF PROPRIETARY STEM CELLS IN THE TREATMENT OF CIRRHOSIS OF THE LIVER
REGENOCYTE EFFECTIVELY CURES CARDIOMYOPATHY PATIENT USING INDIVIDUAL ADULT STEM CELLS
LIMBS WITH PERIPHERAL ARTERIAL DISEASE CAN BE SAVED BY USING ADULT STEM CELLS
GAMIDA CELL LTD. CONTINUATION OF RESEARCH ON STEMEX(R), A CORD BLOOD STEM CELL PRODUCT, FOR LEUKEMIA AND LYMPHOMA
BIOHEART’S INNOVATION OF FIRST FDA GRANT CLINICAL TRIAL TO TEST CONGESTIVE HEART FAILURE FOR GENE-MODIFIED STEM CELL THERAPY
FATE THERAPEUTICS GETS GRANT OF FIRST U.S. COPYRIGHT FOR INDUCED PLURIPOTENT STEM CELL EXPERTISE
STEM CELL THERAPY INTERNATIONAL CORP. COMPLETELY AMALGAMATED WITH HISTOSTEM, CO., LTD.
INDIA THE NEXT POTENTIAL STEM CELL MARKET - CORDLIFE
ROMANIA STARTS ITS EARLIEST STEM CELL FRIENDLY CASE
STEM CELL GROUP MAKES A SUBSTITUTE BONE PIECE
NEW CORD BLOOD THERAPY! A NEW RAY OF HOPE FOR MANY THALASSEMIA AFFECTED PATIENTS.
FLORIDA UNIVERSITY SCIENTISTS DISCOVER THAT BLOOD STEM CELLS CAN BE CHANGED TO VISUALIZATION CELLS
DISSIMILARITY ESTABLISHED BETWEEN EMBRYONIC STEM CELLS AND REPROGRAMMED SKIN CELLS
“BUSH’S STEM CELL RESTRICTIONS TO GO” SAYS PRESIDENT OBAMA
OBAMA TO LIFT THE BAN IMPOSED BY BUSH ON EMBRYONIC STEM CELL RESEARCH
INITIAL STEM CELL TEST GRANTED BY FDA
A STEP FORWARD IN DIABETES TREATMENT DISCOVERED BY NOVOCELL
B. MARKET TRENDS
STEM CELL TREATMENTS GIVE NEW EXPECTATION
NEW METHOD FOUND TO OVERCOME IMMUNE SYSTEM REJECTION OF HUMAN EMBRYONIC STEM CELLS
PLURIPOTENT STEM CELLS GENERATED FROM HORSES FOR THE FIRST TIME
DARK CLOUDS OF UNCERTAINTIES LOOM OVER EMBRYONIC STEM CELL RESEARCH
DONOR STEM CELL RESEARCH MAY REPAIR HEART DAMAGE
HUMAN INDUCED PLURIPOTENT STEM CELLS SHOW MUTATION
PREVALENT MUTATIONS FOUND IN REPROGRAMMED STEM CELLS
ANTI-AGING INDUSTRY GOES FOR STEM CELL THERAPY
STEM CELL TREATMENT TO CURE DIABETES
REVOLUTIONARY STEM CELL REMEDY REINSTATES SIGHT
UCLA STUDY REVEALS THE USE OF STEM CELLS TO DESTROY HIV
STEM CELLS CAPABLE OF ASSISTING ANGINA PATIENTS
AGREEMENT SKETCHING OUT MORAL APPROACH TO STEM CELL PLANNED
HOTTEST DEVELOPMENTS IN STEM CELLS TREATMENTS
EMBRYONIC STEM CELLS STUDY BEING TURNED INTO A CONTENTIOUS DISCUSSION
ADULT STEM CELLS GROWING TO BE A HOPEFUL MARKET
UNITED STATES ORTHOPEDIC STEM CELL FORECASTED TO GENERATE REVENUES WORTH $1.1 BILLION BY 2015
HUMAN EXPERIMENTAL TEST OF STEM CELL BASED MEDICINE
STEM CELLS CAPABLE OF REINSTATING MISPLACED BRAIN TASKS
GROWING HEART VALVES FROM STEM CELLS
STEM CELL TREATMENT COULD POSSIBLY WORK IN OPPOSITION TO BRAIN INFLAMMATION
RESOURCEFUL STEM CELLS DISCOVERED IN AMNIOTIC FLUID
STEM CELL PROGRESS BEING HIT BY TRADITIONALIST
C. INDUSTRY LEADERS
AASTROM BIOSCIENCES, INC.
BIOHEART, INC.
CORD BLOOD REGISTRY
CRYOLIFE, INC.
OSIRIS THERAPEUTICS, INC.
SIGMA-ALDRICH, CO.
STEM CELL INNOVATIONS, INC.
THERMO FISHER SCIENTIFIC, INC
VIACORD
RENEURON GROUP PLC
CRYOCORD SDN. BHD
D. STEM CELLS MARKET – A LOOK A HEAD..!!
E. KEY COMPANY PROFILES
NORTH AMERICA
EUROPE
ASIA-PACIFIC
V. APPENDIX
RESEARCH FOCUS
ABOUT AXIS RESEARCH MIND
DISCLAIMER
FEEDBACK
LIST OF TABLES/CHARTS
I. REPORT FOCUS
1. WORLDWIDE PRODUCT SEGMENTATION OF STEM CELLS MARKET
2. DIFFERENTIAL POTENTIAL RANGES FROM TOTIPOTENT STEM CELLS TO NULLIPOTENT CELLS
3. STEM CELLS BANKING STORAGE PRICE STRUCTURE AROUND THE WORLD
4. STEM CELLS COMPANIES IN DIFFERENT COUNTRIES WITH THEIR NUMBER OF TRANSPLANTS
II. MARKET ANALYSIS
A. STEM CELLS
5. GLOBAL STEM CELLS - SEGMENTATION BY PRODUCTS, APPLICATIONS AND TECHNOLOGIES
6. STEM CELLS – GLOBAL CURRENT TRENDS, ESTIMATES & FORECASTS - (2009-2015, IN USD$ MILLION)
7. STEM CELLS - GEOGRAPHIC REGION CURRENT TRENDS, ESTIMATES & FORECASTS FOR NORTH AMERICA, EUROPE, ASIA-PACIFIC, LATIN AMERICA AND REST OF WORLD - (2009-2015, IN USD$ MILLION)
8. STEM CELLS - % OF NORTH AMERICA, EUROPE, ASIA-PACIFIC, LATIN AMERICA AND REST OF WORLD MARKET VALUE - (2009 - 2012 - 2015)
B. STEM CELLS – BY COUNTRY
9. STEM CELLS - USA, CANADA AND MEXICO - (2009-2015, IN USD$ MILLION)
10. STEM CELLS - % OF USA, CANADA AND MEXICO MARKET VALUE - (2009 - 2012 - 2015)
11. STEM CELLS - BELGIUM, DENMARK, FRANCE, GERMANY, GREECE, SPAIN, SWEDEN, UNITED KINGDOM AND REST OF EUROPE - (2009-2015, IN USD$ MILLION)
12. STEM CELLS - % OF BELGIUM, DENMARK, FRANCE, GERMANY, GREECE, SPAIN, SWEDEN, UNITED KINGDOM AND REST OF EUROPE MARKET VALUE - (2009 - 2012 - 2015)
13. STEM CELLS - AUSTRALIA, CHINA, INDIA, JAPAN, SOUTH KOREA AND REST OF ASIA-PACIFIC - (2009-2015, IN USD$ MILLION)
14. STEM CELLS - % OF AUSTRALIA, CHINA, INDIA, JAPAN, SOUTH KOREA AND REST OF ASIA-PACIFIC MARKET VALUE - (2009 - 2012 - 2015)
15. STEM CELLS - ARGENTINA AND BRAZIL - (2009-2015, IN USD$ MILLION)
16. STEM CELLS - % OF ARGENTINA AND BRAZIL MARKET VALUE - (2009 - 2012 - 2015)
17. STEM CELLS - COLUMBIA, MIDDLE EAST, SOUTH AFRICA AND REST OF REST OF WORLD - (2009-2015, IN USD$ MILLION)
18. STEM CELLS - COLUMBIA, MIDDLE EAST, SOUTH AFRICA AND REST OF REST OF WORLD - % OF REST OF WORLD MARKET VALUE - (2009 - 2012 - 2015)
C. STEM CELLS – PRODUCT SEGMENTS
19. STEM CELL PRODUCTS - ADULT STEM CELLS, CORD BLOOD STEM CELLS, EMBRYONIC STEM CELLS AND OTHERS FOR GLOBAL CURRENT TRENDS, ESTIMATES & FORECASTS - (2009-2015, IN USD$ MILLION)
20. STEM CELL PRODUCTS - ADULT STEM CELLS, CORD BLOOD STEM CELLS, EMBRYONIC STEM CELLS AND OTHERS - % OF GLOBAL MARKET VALUE - (2009 - 2012 - 2015)
ADULT STEM CELLS
21. STEM CELL PRODUCTS - ADULT STEM CELLS BY GEOGRAPHIC REGION CURRENT TRENDS, ESTIMATES & FORECASTS FOR NORTH AMERICA, EUROPE, ASIA-PACIFIC, LATIN AMERICA AND REST OF WORLD - (2009-2015, IN USD$ MILLION)
22. STEM CELL PRODUCTS - ADULT STEM CELLS - % OF NORTH AMERICA, EUROPE, ASIA-PACIFIC, LATIN AMERICA AND REST OF WORLD MARKET VALUE BY GEOGRAPHIC REGION - (2009 - 2012 - 2015)
23. STEM CELL PRODUCTS - ADULT STEM CELLS FOR USA, CANADA AND MEXICO - (2009-2015, IN USD$ MILLION)
24. STEM CELL PRODUCTS - ADULT STEM CELLS - % OF USA, CANADA AND MEXICO MARKET VALUE - (2009 - 2012 - 2015)
25. STEM CELL PRODUCTS - ADULT STEM CELLS FOR DENMARK, FRANCE, GERMANY, SPAIN, SWEDEN, UNITED KINGDOM AND REST OF EUROPE - (2009-2015, IN USD$ MILLION)
26. STEM CELL PRODUCTS - ADULT STEM CELLS - % OF DENMARK, FRANCE, GERMANY, SPAIN, SWEDEN, UNITED KINGDOM AND REST OF EUROPE MARKET VALUE - (2009 - 2012 - 2015)
27. STEM CELL PRODUCTS - ADULT STEM CELLS FOR AUSTRALIA, CHINA, INDIA, JAPAN, SOUTH KOREA AND REST OF ASIA-PACIFIC - (2009-2015, IN USD$ MILLION)
28. STEM CELL PRODUCTS - ADULT STEM CELLS - % OF AUSTRALIA, CHINA, INDIA, JAPAN, SOUTH KOREA AND REST OF ASIA-PACIFIC MARKET VALUE - (2009 - 2012 - 2015)
29. STEM CELL PRODUCTS - ADULT STEM CELLS FOR ARGENTINA AND BRAZIL - (2009-2015, IN USD$ MILLION)
30. STEM CELL PRODUCTS - ADULT STEM CELLS - % OF ARGENTINA AND BRAZIL MARKET VALUE - (2009 - 2012 - 2015)
31. STEM CELL PRODUCTS - ADULT STEM CELLS FOR COLUMBIA, MIDDLE EAST, SOUTH AFRICA AND REST OF REST OF WORLD - (2009-2015, IN USD$ MILLION)
32. STEM CELL PRODUCTS - ADULT STEM CELLS - % OF COLUMBIA, MIDDLE EAST, SOUTH AFRICA AND REST OF REST OF WORLD MARKET VALUE - (2009 - 2012 - 2015)
CORD BLOOD STEM CELLS
33. STEM CELL PRODUCTS - CORD BLOOD STEM CELLS BY GEOGRAPHIC REGION CURRENT TRENDS, ESTIMATES & FORECASTS FOR NORTH AMERICA, EUROPE, ASIA-PACIFIC, LATIN AMERICA AND REST OF WORLD - (2009-2015, IN USD$ MILLION)
34. STEM CELL PRODUCTS - CORD BLOOD STEM CELLS - % OF NORTH AMERICA, EUROPE, ASIA-PACIFIC, LATIN AMERICA AND REST OF WORLD MARKET VALUE BY GEOGRAPHIC REGION - (2009 - 2012 - 2015)
35. STEM CELL PRODUCTS - CORD BLOOD STEM CELLS FOR USA, CANADA AND MEXICO - (2009-2015, IN USD$ MILLION)
36. STEM CELL PRODUCTS - CORD BLOOD STEM CELLS - % OF USA, CANADA AND MEXICO MARKET VALUE - (2009 - 2012 - 2015)
37. STEM CELL PRODUCTS - CORD BLOOD STEM CELLS FOR DENMARK, FRANCE, GERMANY, SPAIN, SWEDEN, UNITED KINGDOM AND REST OF EUROPE - (2009-2015, IN USD$ MILLION)
38. STEM CELL PRODUCTS - CORD BLOOD STEM CELLS - % OF DENMARK, FRANCE, GERMANY, SPAIN, SWEDEN, UNITED KINGDOM AND REST OF EUROPE MARKET VALUE - (2009 - 2012 - 2015)
39. STEM CELL PRODUCTS - CORD BLOOD STEM CELLS FOR AUSTRALIA, CHINA, INDIA, JAPAN, SOUTH KOREA AND REST OF ASIA-PACIFIC - (2009-2015, IN USD$ MILLION)
40. STEM CELL PRODUCTS - CORD BLOOD STEM CELLS - % OF AUSTRALIA, CHINA, INDIA, JAPAN, SOUTH KOREA AND REST OF ASIA-PACIFIC MARKET VALUE - (2009 - 2012 - 2015)
41. STEM CELL PRODUCTS - CORD BLOOD STEM CELLS FOR ARGENTINA AND BRAZIL - (2009-2015, IN USD$ MILLION)
42. STEM CELL PRODUCTS - CORD BLOOD STEM CELLS - % OF ARGENTINA AND BRAZIL MARKET VALUE - (2009 - 2012 - 2015)
43. STEM CELL PRODUCTS - CORD BLOOD STEM CELLS FOR COLUMBIA, MIDDLE EAST, SOUTH AFRICA AND REST OF REST OF WORLD - (2009-2015, IN USD$ MILLION)
44. STEM CELL PRODUCTS - CORD BLOOD STEM CELLS - % OF COLUMBIA, MIDDLE EAST, SOUTH AFRICA AND REST OF REST OF WORLD MARKET VALUE - (2009 - 2012 - 2015)
EMBRYONIC STEM CELLS
45. STEM CELL PRODUCTS - EMBRYONIC STEM CELLS BY GEOGRAPHIC REGION CURRENT TRENDS, ESTIMATES & FORECASTS FOR NORTH AMERICA, EUROPE, ASIA-PACIFIC, LATIN AMERICA AND REST OF WORLD - (2009-2015, IN USD$ MILLION)
46. STEM CELL PRODUCTS - EMBRYONIC STEM CELLS - % OF NORTH AMERICA, EUROPE, ASIA-PACIFIC, LATIN AMERICA AND REST OF WORLD MARKET VALUE BY GEOGRAPHIC REGION - (2009 - 2012 - 2015)
47. STEM CELL PRODUCTS - EMBRYONIC STEM CELLS FOR USA AND CANADA - (2009-2015, IN USD$ MILLION)
48. STEM CELL PRODUCTS - EMBRYONIC STEM CELLS - % OF USA AND CANADA MARKET VALUE - (2009 - 2012 - 2015)
49. STEM CELL PRODUCTS - EMBRYONIC STEM CELLS FOR BELGIUM, DENMARK, FRANCE, GREECE, SPAIN, SWEDEN, UNITED KINGDOM AND REST OF EUROPE - (2009-2015, IN USD$ MILLION)
50. STEM CELL PRODUCTS - EMBRYONIC STEM CELLS - % OF BELGIUM, DENMARK, FRANCE, GREECE, SPAIN, SWEDEN, UNITED KINGDOM AND REST OF EUROPE MARKET VALUE - (2009 - 2012 - 2015)
51. STEM CELL PRODUCTS - EMBRYONIC STEM CELLS FOR AUSTRALIA, CHINA, INDIA, JAPAN, SOUTH KOREA AND REST OF ASIA-PACIFIC - (2009-2015, IN USD$ MILLION)
52. STEM CELL PRODUCTS - EMBRYONIC STEM CELLS - % OF AUSTRALIA, CHINA, INDIA, JAPAN, SOUTH KOREA AND REST OF ASIA-PACIFIC MARKET VALUE - (2009 - 2012 - 2015)
53. STEM CELL PRODUCTS - EMBRYONIC STEM CELLS FOR BRAZIL - (2009-2015, IN USD$ MILLION)
54. STEM CELL PRODUCTS - EMBRYONIC STEM CELLS FOR MIDDLE EAST, SOUTH AFRICA AND REST OF REST OF WORLD - (2009-2015, IN USD$ MILLION)
55. STEM CELL PRODUCTS - EMBRYONIC STEM CELLS - % OF MIDDLE EAST, SOUTH AFRICA AND REST OF REST OF WORLD MARKET VALUE - (2009 - 2012 - 2015)
OTHER STEM CELLS
56. STEM CELL PRODUCTS - OTHER STEM CELLS BY GEOGRAPHIC REGION CURRENT TRENDS, ESTIMATES & FORECASTS FOR NORTH AMERICA, EUROPE, ASIA-PACIFIC, LATIN AMERICA AND REST OF WORLD - (2009-2015, IN USD$ MILLION)
57. STEM CELL PRODUCTS - OTHER STEM CELLS - % OF NORTH AMERICA, EUROPE, ASIA-PACIFIC, LATIN AMERICA AND REST OF WORLD MARKET VALUE BY GEOGRAPHIC REGION - (2009 - 2012 - 2015)
58. STEM CELL PRODUCTS - OTHER STEM CELLS FOR USA, CANADA AND MEXICO - (2009-2015, IN USD$ MILLION)
59. STEM CELL PRODUCTS - OTHER STEM CELLS - % OF USA, CANADA AND MEXICO MARKET VALUE - (2009 - 2012 - 2015)
60. STEM CELL PRODUCTS - OTHER STEM CELLS FOR DENMARK, FRANCE, GERMANY, SPAIN, SWEDEN, UNITED KINGDOM AND REST OF EUROPE - (2009-2015, IN USD$ MILLION)
61. STEM CELL PRODUCTS - OTHER STEM CELLS - % OF DENMARK, FRANCE, GERMANY, SPAIN, SWEDEN, UNITED KINGDOM AND REST OF EUROPE MARKET VALUE - (2009 - 2012 - 2015)
62. STEM CELL PRODUCTS - OTHER STEM CELLS FOR AUSTRALIA, CHINA, INDIA, JAPAN, SOUTH KOREA AND REST OF ASIA-PACIFIC - (2009-2015, IN USD$ MILLION)
63. STEM CELL PRODUCTS - OTHER STEM CELLS - % OF AUSTRALIA, CHINA, INDIA, JAPAN, SOUTH KOREA AND REST OF ASIA-PACIFIC MARKET VALUE - (2009 - 2012 - 2015)
64. STEM CELL PRODUCTS - OTHER STEM CELLS FOR ARGENTINA AND BRAZIL - (2009-2015, IN USD$ MILLION)
65. STEM CELL PRODUCTS - OTHER STEM CELLS - % OF ARGENTINA AND BRAZIL MARKET VALUE - (2009 - 2012 - 2015)
66. STEM CELL PRODUCTS - OTHER STEM CELLS FOR COLUMBIA, MIDDLE EAST, SOUTH AFRICA AND REST OF REST OF WORLD - (2009-2015, IN USD$ MILLION)
67. STEM CELL PRODUCTS - OTHER STEM CELLS - % OF COLUMBIA, MIDDLE EAST, SOUTH AFRICA AND REST OF REST OF WORLD MARKET VALUE - (2009 - 2012 - 2015)
C2. STEM CELLS – BY PRODUCT
NORTH AMERICA
68. STEM CELL PRODUCTS - ADULT STEM CELLS, CORD BLOOD STEM CELLS, EMBRYONIC STEM CELLS AND OTHERS FOR NORTH AMERICA - (2009-2015, IN USD$ MILLION)
69. STEM CELL PRODUCTS - ADULT STEM CELLS, CORD BLOOD STEM CELLS, EMBRYONIC STEM CELLS AND OTHERS - % OF NORTH AMERICAN MARKET VALUE - (2009 - 2012 - 2015)
70. STEM CELL PRODUCTS - ADULT STEM CELLS, CORD BLOOD STEM CELLS, EMBRYONIC STEM CELLS AND OTHERS FOR THE UNITED STATES OF AMERICA - (2009-2015, IN USD$ MILLION)
71. STEM CELL PRODUCTS - ADULT STEM CELLS, CORD BLOOD STEM CELLS, EMBRYONIC STEM CELLS AND OTHERS - % OF THE UNITED STATES OF AMERICA MARKET VALUE - (2009 - 2012 - 2015)
72. STEM CELL PRODUCTS - ADULT STEM CELLS, CORD BLOOD STEM CELLS, EMBRYONIC STEM CELLS AND OTHERS FOR CANADA - (2009-2015, IN USD$ MILLION)
73. STEM CELL PRODUCTS - ADULT STEM CELLS, CORD BLOOD STEM CELLS, EMBRYONIC STEM CELLS AND OTHERS - % OF CANADIAN MARKET VALUE - (2009 - 2012 - 2015)
74. STEM CELL PRODUCTS - ADULT STEM CELLS, CORD BLOOD STEM CELLS, AND OTHERS FOR MEXICO - (2009-2015, IN USD$ MILLION)
75. STEM CELL PRODUCTS - ADULT STEM CELLS, CORD BLOOD STEM CELLS AND OTHERS - % OF MEXICAN MARKET VALUE - (2009 - 2012 - 2015)
EUROPE
76. STEM CELL PRODUCTS - ADULT STEM CELLS, CORD BLOOD STEM CELLS, EMBRYONIC STEM CELLS AND OTHERS FOR EUROPE - (2009-2015, IN USD$ MILLION)
77. STEM CELL PRODUCTS - ADULT STEM CELLS, CORD BLOOD STEM CELLS, EMBRYONIC STEM CELLS AND OTHERS - % OF EUROPEAN MARKET VALUE - (2009 - 2012 - 2015)
78. STEM CELL PRODUCTS - EMBRYONIC STEM CELLS FOR BELGIUM - (2009-2015, IN USD$ MILLION)
79. STEM CELL PRODUCTS - ADULT STEM CELLS, CORD BLOOD STEM CELLS, EMBRYONIC STEM CELLS AND OTHERS FOR DENMARK - (2009-2015, IN USD$ MILLION)
80. STEM CELL PRODUCTS - ADULT STEM CELLS, CORD BLOOD STEM CELLS, EMBRYONIC STEM CELLS AND OTHERS - % OF DANISH MARKET VALUE - (2009 - 2012 - 2015)
81. STEM CELL PRODUCTS - ADULT STEM CELLS, CORD BLOOD STEM CELLS, EMBRYONIC STEM CELLS AND OTHERS FOR FRANCE - (2009-2015, IN USD$ MILLION)
82. STEM CELL PRODUCTS - ADULT STEM CELLS, CORD BLOOD STEM CELLS, EMBRYONIC STEM CELLS AND OTHERS - % OF FRENCH MARKET VALUE - (2009 - 2012 - 2015)
83. STEM CELL PRODUCTS - ADULT STEM CELLS, CORD BLOOD STEM CELLS, AND OTHERS FOR GERMANY - (2009-2015, IN USD$ MILLION)
84. STEM CELL PRODUCTS - ADULT STEM CELLS, CORD BLOOD STEM CELLS AND OTHERS - % OF GERMAN MARKET VALUE - (2009 - 2012 - 2015)
85. STEM CELL PRODUCTS - EMBRYONIC STEM CELLS FOR GREECE - (2009-2015, IN USD$ MILLION)
86. STEM CELL PRODUCTS - ADULT STEM CELLS, CORD BLOOD STEM CELLS, EMBRYONIC STEM CELLS AND OTHERS FOR SPAIN - (2009-2015, IN USD$ MILLION)
87. STEM CELL PRODUCTS - ADULT STEM CELLS, CORD BLOOD STEM CELLS, EMBRYONIC STEM CELLS AND OTHERS - % OF SPANISH MARKET VALUE - (2009 - 2012 - 2015)
88. STEM CELL PRODUCTS - ADULT STEM CELLS, CORD BLOOD STEM CELLS, EMBRYONIC STEM CELLS AND OTHERS FOR SWEDEN - (2009-2015, IN USD$ MILLION)
89. STEM CELL PRODUCTS - ADULT STEM CELLS, CORD BLOOD STEM CELLS, EMBRYONIC STEM CELLS AND OTHERS - % OF SWEDISH MARKET VALUE - (2009 - 2012 - 2015)
90. STEM CELL PRODUCTS - ADULT STEM CELLS, CORD BLOOD STEM CELLS, EMBRYONIC STEM CELLS AND OTHERS FOR THE UNITED KINGDOM - (2009-2015, IN USD$ MILLION)
91. STEM CELL PRODUCTS - ADULT STEM CELLS, CORD BLOOD STEM CELLS, EMBRYONIC STEM CELLS AND OTHERS - % OF THE UNITED KINGDOM MARKET VALUE - (2009 - 2012 - 2015)
92. STEM CELL PRODUCTS - ADULT STEM CELLS, CORD BLOOD STEM CELLS, EMBRYONIC STEM CELLS AND OTHERS FOR REST OF EUROPE - (2009-2015, IN USD$ MILLION)
93. STEM CELL PRODUCTS - ADULT STEM CELLS, CORD BLOOD STEM CELLS, EMBRYONIC STEM CELLS AND OTHERS - % OF REST OF EUROPE MARKET VALUE - (2009 - 2012 - 2015)
ASIA-PACIFIC
94. STEM CELL PRODUCTS - ADULT STEM CELLS, CORD BLOOD STEM CELLS, EMBRYONIC STEM CELLS AND OTHERS FOR ASIA-PACIFC - (2009-2015, IN USD$ MILLION)
95. STEM CELL PRODUCTS - ADULT STEM CELLS, CORD BLOOD STEM CELLS, EMBRYONIC STEM CELLS AND OTHERS - % OF ASIA-PACIFIC MARKET VALUE - (2009 - 2012 - 2015)
96. STEM CELL PRODUCTS - ADULT STEM CELLS, CORD BLOOD STEM CELLS, EMBRYONIC STEM CELLS AND OTHERS FOR AUSTRALIA - (2009-2015, IN USD$ MILLION)
97. STEM CELL PRODUCTS - ADULT STEM CELLS, CORD BLOOD STEM CELLS, EMBRYONIC STEM CELLS AND OTHERS - % OF AUSTRALIAN MARKET VALUE - (2009 - 2012 - 2015)
98. STEM CELL PRODUCTS - ADULT STEM CELLS, CORD BLOOD STEM CELLS, EMBRYONIC STEM CELLS AND OTHERS FOR CHINA - (2009-2015, IN USD$ MILLION)
99. STEM CELL PRODUCTS - ADULT STEM CELLS, CORD BLOOD STEM CELLS, EMBRYONIC STEM CELLS AND OTHERS - % OF CHINESE MARKET VALUE - (2009 - 2012 - 2015)
100. STEM CELL PRODUCTS - ADULT STEM CELLS, CORD BLOOD STEM CELLS, EMBRYONIC STEM CELLS AND OTHERS FOR INDIA - (2009-2015, IN USD$ MILLION)
101. STEM CELL PRODUCTS - ADULT STEM CELLS, CORD BLOOD STEM CELLS, EMBRYONIC STEM CELLS AND OTHERS - % OF INDIAN MARKET VALUE - (2009 -
